RxDoctor Payments DataLook up a doctor →

BALFAXAR: payments to doctors

Payments that named BALFAXAR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$107K
Providers
465
Transactions
660
Average per transaction
$162

The per-transaction average — $162 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 465 providers the average total is $230, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Octapharma USA, Inc.$106,876100.0%
← All drugs & devices